Modes of treatment for cerebral vasospasm following aneurysmal subarachnoid haemorrhage
British Journal of Neuroscience Nursing · 2005
DOI: 10.12968/bjnn.2005.1.1.20 ↗Abstract
Delayed cerebral vasospasm (DCV) is a life-threatening complication of aneurysmal subarachnoid haemorrhage (SAH). Advances in understanding the pathogenesis of DCV have led to the development of new forms of treatment, some of which are currently undergoing clinical trials. Although some treatments have demonstrated improved outcomes for patients following SAH, none has been found to unequivocally overcome DCV. This article reviews current treatments and those undergoing clinical trials. It focuses on the mode of action of each treatment and possible complications, and reviews some of the clinical trials that have been conducted to determine their efficacy. To gain a greater understanding of the mode of action of each treatment, the current theories of the pathogenesis of DCV are discussed briefly. With increasing use of new therapies to treat vasospasm, nurses need to be familiar with how they are used, their mode of action and possible complications.
EUVIMED